Abstract:Objective To analysis the modified Gleason scoring system for predicting the prognosis after radical prostatectomy.Methods A total of 242 patients who received radical prostatectomy from April,2006 to October 2011 were recruited.The patients who lost follow-up or had adjuvant radiation or hormonal therapy or had visceral or bone metastasis were excluded,the remaining 168 patients were evaluated in the present study.The patients' age ranged from 53 to 85 years old (mean age 69 years old).The mean PSA level was 13.31ng/ml (ranging from 4.59 to 36.12 ng/ml).According to the traditional Gleason scoring system,there were 50 patients in Gleason ≤ 6 group,86 patients in Gleason 7 group and 32 patients in Gleason≥8 group.Patients were divided in five groups according to the modified Gleason scoring system.There were 50 patients in Gleason ≤6 group,67 in Gleason 3 + 4 group,19 in Gleason 4 + 3 group,15 in Gleason 8 group and 17 in Gleason 9-10 group.The biochemical-free-survival curve was drawn by Kaplan-Meier method and the multivariate Cox regression models were used to evaluate the clinical and pathological variables for the development of biochemical recurrence.ROC curve analysis was used to determine the predicted value for 5-year BCR of modified and traditional Gleason scoring.Results Significant differences were noted between the modified Gleason scoring groups and traditional Gleason scoring groups in PSA value (P =0.005),pathological stage (P =0.002),extraprostatic extension (P =0.003),seminal vesicle invasion (P =0.004),lymph node involvement (P =0.049) and positive surgical margin (P =0.006).With a median follow-up of 68 months(ranging from 7 to 98 months),5-year BFS rates for men with Gleason grade ≤6,3 + 4,4 + 3,8 and 9-10 tumours on RP pathology were 84.0％ (42/50),76.1％ (51/67),57.9％(11/19),40.0％ (9/15),29.4％ (5/17),respectively.On multivariate analysis,the HR value of Gleason 3 + 4 group and Gleason 4 + 3 group were 1.736 and 2.075 (P ＜ 0.05).The area under the curve in modified and traditional Gleason scoring were 0.698 (95％ CI 0.609-0.788) and 0.674 (95％ CI O.584-0.764),respectively.Conclusions The modified Gleason scoring system is related to the prostate cancer grade and its survival rate.Therefore,it can predict prognosis accurately in patients with prostate cancer.It can potential to reduce overtreatment in patients with Gleason 3 +4 prostate cancer.

[Reproducibility of Gleason Scores in Prostate Cancer].

[Impact of International Association of Urological Pathology Gleason Scoring System on Prostatic Carcinoma Grading: a Preliminary Analysis of 185 Cases].

Evaluation of the accuracy of biopsy Gleason score as predictors of histological grading of prostate cancer specimens

Evaluation of Gleason Score Concordance Between Prostate Biopsy and Prostatectomy Specimens of Prostate Cancer

Distribution features of Gleason score and its relationship with clinical stages in 346 prostate cancer patients]

Prognostic Significance of Modified Gleason Scoring System after Radical Prostatectomy

[Concordance Between Three Integrated Scores Based on Prostate Biopsy and Grade-Grouping of Radical Prostatectomy Specimen].

Evaluation of Gleason Grading As Compared to Histological Grading of Radical Prostatectomy Specimens of Prostate Cancer

Basic Features of the ISUP Prostate Carcinoma Gleason Grading System: A Preliminary Analysis

Cmar_a_196286 6521..6529

Gene Expression Analysis Reveals a Pitfall in the Molecular Research of Prostate Tumors Relevant to Gleason Score

Prognostic Models for Patients with Gleason Score 9 Prostate Cancer: A Population-Based Study.

Correlation analysis of positive margins after radical prostatectomy with Gleason score of biopsy specimens and percentage of positive biopsy cores in prostate cancer

Correlation analysis of prostate biopsy and radical prostatectomy specimen

Pathological features, Gleason grading and prognostic grade grouping of prostatic carcinoma: analyses of 119 cases of prostate needle biopsy specimens

Clinical Characteristics of Patients after Radical Prostatectomy for Prostate Cancer:A Comparison Between Gleason Score 3+4 and Gleason Score 4+3

Exploration on Gleason Score Variation Trend of Patients with Prostate Carcinoma from 1996 to 2019: a Retrospective Single Center Study

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

The Validation of the 2014 International Society of Urological Pathology (ISUP) Grading System for Patients with High-Risk Prostate Cancer: a Single-Center Retrospective Study.

The predictive value of serum PSA to Gleason score in patients with prostate adenocarcinoma

Systematic Biopsy vs. Prostatectomy: Evaluating Correlations and Grading Discrepancies in Prostate Cancer